Christian Angermayer is an entrepreneur, investor and a thriving force in the current psychedelic field. He is the founder of Apeiron Investment Group and the biotech company ATAI Life Sciences. ATAI’s focus is developing solutions to help the more than 300 million people globally who suffer from depression. Their research explores the use of psychedelic compounds to heal a broad range of mental health disorders alongside depression. This is Christian’s second appearance on the show. In this episode we really dive into his personal journey towards psychedelics and how he became a driving force in this exciting new industry. And we also talk about racial trauma, and the new ways we’re beginning to understand it and redefine our notions of mental health on a broader scale.
Hosted on Acast. See acast.com/privacy for more information.